Regression of retroperitoneal fibrosis to a combined tamoxifen and steroid therapy;Ruckbildung der retroperitonealfibrose durch eine kombinationstherapie von tamoxifen und steroiden

Medizinische Klinik

Volumn 92, Issue 7, 1997, Pages 439-443

  Allendorff, Joachim ^a   Riegel, Werner ^a   Köhler, Hans ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Combined tamoxifen; Retroperitoneal fibrosis; Steroid therapy; Treatment

Indexed keywords

STEROID; TAMOXIFEN; ANTIESTROGEN; ANTIINFLAMMATORY AGENT; METHYLPREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; HUMAN; ILIAC VEIN; INFERIOR CAVA VEIN; REMISSION; RETROPERITONEAL FIBROSIS; URETER OBSTRUCTION; URETER SURGERY; VEIN THROMBOSIS; AGED; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; FOLLOW UP; MIDDLE AGED; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ESTROGEN ANTAGONISTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; METHYLPREDNISOLONE; MIDDLE AGED; RETROPERITONEAL FIBROSIS; TAMOXIFEN; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0031570858     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03042577     Document Type: Article

References (28)

1. Amis, E. S.: Retroperitoneal fibrosis. Amer. j. R̈oentgenol. 157 (1991), 321-329.
2. Baker, L. R. I., J. W. Mallinson, M. C. Gregory, E. A. D. Menzies, W. R. Cattell, H. N. Whitfield; W. F. Hendry, J. E. A.Wickham, A. M. Joekes: Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Brit. J. Urol. 60 (1980), 497-503.
3. Benson, J. R., M. Baum: Tamoxiferi for retroperitoneal fibrosis. Lancet 341 (1993), 836.
4. Carton, R. W., R. Wong: Multifocal fibrosclerosis manifested by vena cava obstructions and associated with vasculitis. Ann. intern. Med. 70 (1969), 81-86.
5. Clark, C. P., D. Vanderpool J. T. Preskitt. The response of retroperitoneal fibrosis to tamoxifen. Surgery 109 (1991), 502-506.
6. Collecta, A. A., L. M. Wakefield, F. V. Howell, K. E. P. van Roozendaal, D. Danielpour, S. R. Ebbs, M. B. Sporn, M. Baurn: Anti-oestrogens induce die secretion of active transforming growth factor beta from human fetal fibroblasts. Brit. J. Cancer 62 (1990), 405-409.
7. Comings, D. E., K. B. Skubi, J. van Eyes, A. G. Motulsky: Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangiatis. Rieders thyreoiditis and pseudotumor of the orbit may be different manifestations of a single disease. Ann intern. Med. 66 (1967), 884-892.
8. Devevey, J. M., F. Michel, D. Chevet, G. Rifle, L. Arnould: Regression of retroperitoneal fibrosis treated by tamoxifen. Progr. Urol. 6 (1996), 578-581.
9. Gulino, A., G. Barrerea, A. Vacca, A. Farina, C. Ferretti, I. Screpanti, M.U. Dianzani, L. Frati: Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. Cancer Res. 46 (1986), 6274-6278.
10. Horgan, K., E Cooke, M. B. Hallett, R B. Mansel: Inhibition of protein kinase C mediated signal transduction by tamoxifen. Biochem. Pharmacol. 35 (1986), 4463-4465.
11. Kinzbrunner, B., S. Ritter, J. Domingo, C. J. Rosenthal: Remission of rapidly growing desmoid tumors after tamoxifen therapy. Cancer 52 (1983), 2201-2204.
12. Koga, M., R. Sutherland: Epidermal growth factor partially reverses the inhibitory effects of antiestrogens on T-47D human breast cancer cell growth. Biochem. biophys. Res. Commun. 146 (1987), 739-745.
13. Kroeger, E., L Brandes: Evidence that tamoxifen is a histamine antagonist. Biochem. biophys. Res. Commun. 131 (1985), 760-765.
14. Lepor, H., P. Walsh: Idiopathic retroperitoneal fibrosis. J Urol. 122 (1979), 1-6.
15. Littlejohn, G. O., E. C. Keystone: The association of retroperitoneal fibrosis with systemic vasculitis and HLA-B27: a case report and review of the literature. J. Rheum. 8 (1981), 665-669.
16. Loffeld, R. J. L. F., T. F. van Weel: Tamoxifen for retroperitoneal fibrosis. Lancet 341 (1993), 382.
17. McDougal, W. S., R. C. MacDonell: Treatment of idiopathic retroperitoneal fibrosis by immunosuppression. J. Urol. 145 (1991), 112-114.
18. Mitchell, R.: Alimentary complications of non-malignant retroperitoneal fibrosis. Brit. J. Surg. 58 (1971), 254-256.
19. O'Brian, C. A , G. M. Housey, I. B. Weinstein: Specific and direct binding of protein kinase C to an immobilized tamoxifen analogue. Cancer Res 48 (1988), 3626-3629.
20. Onnond, J. K.: Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process J Urol. 59 (1948), 1072-1079.
21. Owens, L. V., W. G. Cance, J. F. Huth: Retroperitoneal fibrosis treated with tamoxifen. Amer. Surg. 61 (1991), 842-844.
22. Piegsa, M., P. Fiegel: Retroperitonealfibrose. Dtsch. med. Wschr. 118 (1993), 1759-1764.
23. Procter, H , L. Singh, M. Baum, D. Brinkley: Response of multicentric desmoid tumors to tamoxifen. Brit. J, Surg. 74 (1987), 401.
24. Ross, J. C., H. J. Goldsmith: The combined surgical and medical treatment of retroperitoneal fibrosis. Brit. J. Surg. 58 (1971), 422-427.
25. Snow, N., E. Kursh: Peripheral ischemia due to retroperitoneal fibrosis. Amer. J. Surg. 133 (1977), 640-642.
26. Spillane, R. M., G. J. Whitman: Treatment of retroperitoneal fibrosis with tamoxifen. Amer. J. Roentgenol. 164 (1995), 515-516.
27. Zabetakis, P. M., R. K. Novich, R. A. Matarese, M. F. Michelis: Idiopathic retroperitoneal fibrosis: a systemic connective tissue disease? J. Urol. 122 (1979), 100-102.
28. Case records of the Massachusetts General Hospital. Weekly dinicopathological exercises. Case 27-1996. A 31-year-old woman with lumbar and abdominal pain, hypertension, and a retroperitoneal mass. New Engl. J. Med. 335 (1996), 650-655.